Concepedia

Publication | Open Access

Fulranumab for treatment of diabetic peripheral neuropathic pain

46

Citations

16

References

2014

Year

Abstract

This study provides Class I evidence that in patients with DPNP, fulranumab 10 mg reduces pain by 1.2 points on an 11-point scale compared with placebo.

References

YearCitations

Page 1